The first doses of the Pfizer COVID-19 shots to be dispatched to Africa under the global COVAX vaccine-sharing scheme were to arrive in Rwanda on Wednesday, as efforts to inoculate the world's poorest ...
South Africa is going with the COVAX global COVID-19 vaccine distribution scheme, with a committed purchase for 10% of its population of 58 million, a senior health official said on Tuesday.
Live Science on MSN
Future pandemics are a 'certainty' — and we must be better prepared to distribute vaccines equitably, says Dr. Seth Berkley
Months before COVID-19 was declared a pandemic, efforts were already underway to ensure low-income countries would get access ...
Even so, Berkley gives Trump credit for Operation Warp Speed. White House spokesperson Kush Desai said in response: “President Trump’s Operation Warp Speed was a bold and innovative public-private ...
Live Science on MSN
'This is a completely different level of anti-vaccine engagement than we've ever seen before,' says epidemiologist Dr. Seth Berkley
Epidemiologist Dr. Seth Berkley spoke to Live Science about the importance of vaccine equity and the obstacles undermining it, as well as the political challenges to vaccines being raised in the U.S.
For those working in global health, and especially on immunisation, it is difficult not to feel despair at the headwinds in ...
Seth Berkley, former CEO of Gavi, the Vaccine Alliance and co-founder of COVAX, discusses his new book “Fair Doses” and the ...
The former head of the international vaccine access organisation Gavi tells The BMJ about the politicising of vaccination, chaos at the CDC, and the impact on global vaccine equity ### Biography Seth ...
GENEVA (AP) — The global initiative to share coronavirus vaccines equally between rich and poor countries asked Wednesday for $5.2 billion in funds to be able to keep buying doses in coming months.
Moderna's mRNA-1273 vaccine helped prevent medically attended COVID-19 and related hospitalizations across multiple respiratory seasons among adults.
The fall COVID-19 vaccine season is starting slowly for Pfizer, with U.S. sales of its Comirnaty shots sinking 25% after federal regulators narrowed recommendations on who should get them.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results